US Stock MarketDetailed Quotes

XENE Xenon Pharmaceuticals

Watchlist
  • 39.500
  • -1.590-3.87%
Close Apr 24 16:00 ET
  • 39.500
  • 0.0000.00%
Post 16:20 ET
2.98BMarket Cap-14468P/E (TTM)

Xenon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
-48.83%9.43M
0
-98.38%132K
-75.83%536K
101.15%8.77M
Operating revenue
--0
--0
--0
--0
--0
-48.83%9.43M
--0
-98.38%132K
-75.83%536K
101.15%8.77M
Cost of revenue
Gross profit
Operating expense
54.47%214.05M
23.92%53.7M
45.54%55.68M
80.30%55.62M
87.68%49.05M
42.23%138.58M
51.64%43.33M
61.28%38.26M
24.82%30.85M
28.01%26.14M
Selling and administrative expenses
41.85%46.54M
48.44%12.62M
45.02%12.8M
33.07%11.58M
40.74%9.54M
49.36%32.81M
27.11%8.5M
82.76%8.83M
37.32%8.71M
64.88%6.78M
-General and administrative expense
41.85%46.54M
48.44%12.62M
45.02%12.8M
33.07%11.58M
40.74%9.54M
49.36%32.81M
27.11%8.5M
82.76%8.83M
37.32%8.71M
64.88%6.78M
Research and development costs
58.38%167.51M
17.93%41.08M
45.70%42.88M
98.86%44.04M
104.11%39.52M
40.16%105.77M
59.14%34.83M
55.79%29.43M
20.51%22.15M
18.71%19.36M
Operating profit
-65.75%-214.05M
-23.92%-53.7M
-46.04%-55.68M
-83.49%-55.62M
-182.41%-49.05M
-63.49%-129.14M
-74.45%-43.33M
-144.44%-38.13M
-34.75%-30.32M
-8.16%-17.37M
Net non-operating interest income expense
217.00%27.62M
94.73%8.69M
127.72%6.98M
699.51%6.52M
1,373.64%5.42M
1,769.74%8.71M
2,236.65%4.46M
5,278.95%3.07M
1,033.33%816K
152.05%368K
Non-operating interest income
217.00%27.62M
94.73%8.69M
127.72%6.98M
699.51%6.52M
1,373.64%5.42M
1,769.74%8.71M
2,236.65%4.46M
5,278.95%3.07M
1,033.33%816K
152.05%368K
Other net income (expense)
177.70%3.75M
-97.86%56K
103.10%83K
183.52%1.42M
171.53%2.19M
-1,236.57%-4.83M
703.23%2.61M
-2,354.13%-2.68M
-1,799.00%-1.7M
-3,881.48%-3.06M
Gain on sale of security
177.70%3.75M
-97.86%56K
103.10%83K
183.52%1.42M
171.53%2.19M
-1,236.57%-4.83M
703.23%2.61M
-2,354.13%-2.68M
-1,799.00%-1.7M
-3,881.48%-3.06M
Income before tax
-45.85%-182.69M
-23.97%-44.95M
-28.84%-48.62M
-52.83%-47.68M
-106.52%-41.44M
-58.78%-125.26M
-44.56%-36.26M
-141.13%-37.74M
-39.74%-31.2M
-26.73%-20.06M
Income tax
-347.46%-292K
-118.00%-205K
73.25%-157K
-450.00%-220K
173.60%290K
2,066.67%118K
135.33%1.14M
-186.34%-587K
81.57%-40K
-479.41%-394K
Net income
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
-140.53%-37.15M
-40.93%-31.16M
-24.78%-19.67M
Net income continuous Operations
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
-140.53%-37.15M
-40.93%-31.16M
-24.78%-19.67M
Minority interest income
Net income attributable to the parent company
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
-58.94%-125.37M
-46.28%-37.4M
-140.53%-37.15M
-40.93%-31.16M
-24.78%-19.67M
Preferred stock dividends
75.65%-437K
96.51%-17K
29.31%-299K
Other preferred stock dividends
Net income attributable to common stockholders
-45.99%-182.39M
-19.70%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-115.41%-41.73M
-62.07%-124.94M
-49.05%-37.38M
-146.30%-37.15M
-44.33%-31.16M
-26.27%-19.37M
Basic earnings per share
-32.52%-2.73
-12.28%-0.64
-28.07%-0.73
-30.91%-0.72
-80.00%-0.63
-16.38%-2.06
-18.75%-0.57
-58.33%-0.57
-7.84%-0.55
16.67%-0.35
Diluted earnings per share
-32.52%-2.73
-12.28%-0.64
-28.07%-0.73
-30.91%-0.72
-80.00%-0.63
-16.38%-2.06
-18.75%-0.57
-58.33%-0.57
-7.84%-0.55
16.67%-0.35
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 00000-48.83%9.43M0-98.38%132K-75.83%536K101.15%8.77M
Operating revenue --0--0--0--0--0-48.83%9.43M--0-98.38%132K-75.83%536K101.15%8.77M
Cost of revenue
Gross profit
Operating expense 54.47%214.05M23.92%53.7M45.54%55.68M80.30%55.62M87.68%49.05M42.23%138.58M51.64%43.33M61.28%38.26M24.82%30.85M28.01%26.14M
Selling and administrative expenses 41.85%46.54M48.44%12.62M45.02%12.8M33.07%11.58M40.74%9.54M49.36%32.81M27.11%8.5M82.76%8.83M37.32%8.71M64.88%6.78M
-General and administrative expense 41.85%46.54M48.44%12.62M45.02%12.8M33.07%11.58M40.74%9.54M49.36%32.81M27.11%8.5M82.76%8.83M37.32%8.71M64.88%6.78M
Research and development costs 58.38%167.51M17.93%41.08M45.70%42.88M98.86%44.04M104.11%39.52M40.16%105.77M59.14%34.83M55.79%29.43M20.51%22.15M18.71%19.36M
Operating profit -65.75%-214.05M-23.92%-53.7M-46.04%-55.68M-83.49%-55.62M-182.41%-49.05M-63.49%-129.14M-74.45%-43.33M-144.44%-38.13M-34.75%-30.32M-8.16%-17.37M
Net non-operating interest income expense 217.00%27.62M94.73%8.69M127.72%6.98M699.51%6.52M1,373.64%5.42M1,769.74%8.71M2,236.65%4.46M5,278.95%3.07M1,033.33%816K152.05%368K
Non-operating interest income 217.00%27.62M94.73%8.69M127.72%6.98M699.51%6.52M1,373.64%5.42M1,769.74%8.71M2,236.65%4.46M5,278.95%3.07M1,033.33%816K152.05%368K
Other net income (expense) 177.70%3.75M-97.86%56K103.10%83K183.52%1.42M171.53%2.19M-1,236.57%-4.83M703.23%2.61M-2,354.13%-2.68M-1,799.00%-1.7M-3,881.48%-3.06M
Gain on sale of security 177.70%3.75M-97.86%56K103.10%83K183.52%1.42M171.53%2.19M-1,236.57%-4.83M703.23%2.61M-2,354.13%-2.68M-1,799.00%-1.7M-3,881.48%-3.06M
Income before tax -45.85%-182.69M-23.97%-44.95M-28.84%-48.62M-52.83%-47.68M-106.52%-41.44M-58.78%-125.26M-44.56%-36.26M-141.13%-37.74M-39.74%-31.2M-26.73%-20.06M
Income tax -347.46%-292K-118.00%-205K73.25%-157K-450.00%-220K173.60%290K2,066.67%118K135.33%1.14M-186.34%-587K81.57%-40K-479.41%-394K
Net income -45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M-140.53%-37.15M-40.93%-31.16M-24.78%-19.67M
Net income continuous Operations -45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M-140.53%-37.15M-40.93%-31.16M-24.78%-19.67M
Minority interest income
Net income attributable to the parent company -45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M-58.94%-125.37M-46.28%-37.4M-140.53%-37.15M-40.93%-31.16M-24.78%-19.67M
Preferred stock dividends 75.65%-437K96.51%-17K29.31%-299K
Other preferred stock dividends
Net income attributable to common stockholders -45.99%-182.39M-19.70%-44.74M-30.45%-48.46M-52.32%-47.46M-115.41%-41.73M-62.07%-124.94M-49.05%-37.38M-146.30%-37.15M-44.33%-31.16M-26.27%-19.37M
Basic earnings per share -32.52%-2.73-12.28%-0.64-28.07%-0.73-30.91%-0.72-80.00%-0.63-16.38%-2.06-18.75%-0.57-58.33%-0.57-7.84%-0.5516.67%-0.35
Diluted earnings per share -32.52%-2.73-12.28%-0.64-28.07%-0.73-30.91%-0.72-80.00%-0.63-16.38%-2.06-18.75%-0.57-58.33%-0.57-7.84%-0.5516.67%-0.35
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg